Senate Bill 136 primarily eliminates the requirement for healthcare providers to notify patients about dense breast tissue after mammography. This change directly impacts patients undergoing mammograms and the medical facilities that perform these screenings in Michigan. The bill also enacts broader amendments concerning the use of radiation machines for mammography procedures. These modifications are made by amending and repealing specific sections within the existing Public Health Code.
SB 405 amends Michigan's "Administration of Opioid Antagonists Act" by revising the definition of "governmental agency" to explicitly exclude school district boards, public school academies, and licensed healthcare providers (under Public Health Code Part 209). This change means these entities will no longer be subject to the act's requirements regarding opioid antagonist access and training. The bill directly affects school districts, public school academies, and licensed healthcare facilities by removing them from the scope of the law. The amendment clarifies which organizations must comply with the act's provisions, focusing on state and local government entities rather than schools or healthcare providers. This is a technical definitional update with no new requirements or funding changes.
SB 154 makes it a crime to obstruct access to healthcare facilities, such as clinics or hospitals. It directly affects individuals who block entrances, interfere with patients or staff, or prevent access to medical services. The bill creates new criminal penalties for these actions under a newly established legal section. This law applies broadly to all healthcare facilities providing medical services, without specifying particular types of care.
SB 155 amends sentencing guidelines to address crimes specifically targeting access to healthcare facilities, such as blocking entrances or threatening staff. It would establish new sentencing standards for these offenses under Michigan's criminal code (MCL 777.13n). The bill directly affects individuals convicted of obstructing healthcare access, potentially altering their prison terms or penalties. However, the provided context does not detail the exact sentencing changes or specific crime definitions. This summary is based solely on the bill's title and official reference, without additional policy specifics.
SB 180 is a funding bill that allocates $39.29 billion to Michigan's Department of Health and Human Services (DHHS) for the 2025-2026 fiscal year. It provides specific funding for key programs including $276 million for department administration and management, $195 million for child support enforcement operations, and $197 million for community services like homeless programs, diaper assistance, and housing support. The bill directly affects DHHS operations and the state's recipients of these services, such as families using child support enforcement, homeless individuals accessing shelter programs, and low-income households receiving food or housing aid. It establishes the financial framework for these programs but does not change their underlying policies or eligibility rules.
SB 3 creates a Prescription Drug Affordability Board to establish maximum payment limits for certain prescription drugs, including brand-name, generic, biologic, and biosimilar medications. The Board, appointed by the governor with health care expertise, will review drug costs and set these limits to improve affordability for Michigan residents. It also establishes a Prescription Drug Affordability Stakeholder Council to provide input and a fund to support the program. This law directly affects drug manufacturers, health insurers, pharmacy benefit managers, and state agencies by requiring adherence to the set payment limits.
Senate Bill 4 amends Michigan's insurance code to require health insurers that provide prescription drug coverage to comply with section 12 of the prescription drug cost and affordability review act. This means insurers delivering or renewing health policies in the state must adhere to specific provisions outlined in that separate act related to prescription drug costs. The bill's enactment is dependent on Senate Bill No. 3 also becoming law.
Senate Bill 5 mandates that Michigan's medical assistance program, which includes Medicaid, must comply with section 12 of the "prescription drug cost and affordability review act," subject to federal law. This means the state's program for medical assistance will be required to follow specific rules related to prescription drug costs and affordability outlined in that separate act. The bill will only become effective if Senate Bill No. 3 of the 103rd Legislature is also passed into law.
Senate Bill 33 amends Michigan's Estates and Protected Individuals Code concerning patient advocate designations. The bill allows individuals to include specific instructions within their patient advocate designation regarding desired life-sustaining treatment, even if they are pregnant. It removes the existing legal prohibition that prevents patient advocates from making decisions to withhold or withdraw life-sustaining treatment from a pregnant patient if such a decision would result in the patient's death. This change enables a patient advocate to follow a pregnant patient's pre-expressed wishes concerning end-of-life care.
